123 related articles for article (PubMed ID: 6230876)
21. Comparison of DNA damage by methylmelamines and formaldehyde.
Ross WE; McMillan DR; Ross CF
J Natl Cancer Inst; 1981 Jul; 67(1):217-21. PubMed ID: 6788992
[TBL] [Abstract][Full Text] [Related]
22. Analogues of hexamethylmelamine. The anti-neoplastic activity of derivatives with enhanced water solubility.
Cumber AJ; Ross WC
Chem Biol Interact; 1977 Jun; 17(3):349-57. PubMed ID: 407012
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of hexamethylmelamine and pentamethylmelamine in mice.
Broggini M; Colombo T; D'Incalci M; Donnelli MG; Gescher A; Garattini S
Cancer Treat Rep; 1981; 65(7-8):669-72. PubMed ID: 6788370
[TBL] [Abstract][Full Text] [Related]
24. [Antitumor activity and toxicity of some ethylenimie derivatives of phosphoric and phosphinic acids and their structure].
Chernov VA; Volodarskaia SM; Gavrilova AI
Farmakol Toksikol; 1965; 28(1):70-3. PubMed ID: 5845050
[No Abstract] [Full Text] [Related]
25. [Antineoplastic nitrosoureas].
Tang WC
Yao Xue Xue Bao; 1982 Jun; 17(6):472-9. PubMed ID: 7148473
[No Abstract] [Full Text] [Related]
26. Antitumor activity of hexamethylmelamine on human tumor xenografts serially transplanted in nude mice.
Kubota T; Tanino H; Watanabe M; Kitajima M
Anticancer Res; 1994; 14(6B):2521-4. PubMed ID: 7872676
[TBL] [Abstract][Full Text] [Related]
27. Antitumour action of 1,5-dihalogeno-, and 1, 2-4, 5-dianhydro-xylitol derivatives.
Jeney A; Kopper L; Lapis K; Vidra L; Institoris L
Anticancer Res; 1984; 4(1-2):23-5. PubMed ID: 6712173
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, structure and anticancer activity of novel alkenyl-1,3,5-triazine derivatives.
Saczewski F; Bułakowska A
Eur J Med Chem; 2006 May; 41(5):611-5. PubMed ID: 16540207
[TBL] [Abstract][Full Text] [Related]
29. Cellular and subcellular studies of the biotransformation of hexamethylmelamine in rat isolated hepatocytes and intestinal epithelial cells.
Borm PJ; Mingels MJ; Frankhuijzen-Sierevogel AC; van Graft M; Hulshoff A; Noordhoek J
Cancer Res; 1984 Jul; 44(7):2820-6. PubMed ID: 6426787
[TBL] [Abstract][Full Text] [Related]
30. Prodrugs in cancer chemotherapy.
Wilman DE
Biochem Soc Trans; 1986 Apr; 14(2):375-82. PubMed ID: 3086154
[No Abstract] [Full Text] [Related]
31. Structure-based design and synthesis of novel macrocyclic pyrazolo[1,5-a] [1,3,5]triazine compounds as potent inhibitors of protein kinase CK2 and their anticancer activities.
Nie Z; Perretta C; Erickson P; Margosiak S; Lu J; Averill A; Almassy R; Chu S
Bioorg Med Chem Lett; 2008 Jan; 18(2):619-23. PubMed ID: 18055206
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, structure and anticancer activity of novel 2,4-diamino-1,3,5-triazine derivatives.
Saczewski F; Bułakowska A; Bednarski P; Grunert R
Eur J Med Chem; 2006 Feb; 41(2):219-25. PubMed ID: 16377034
[TBL] [Abstract][Full Text] [Related]
33. Hexamethylmelamine and hexamethylmelamine hydrochloride.
van de Vaart-van Zutphen HP; Smulders CF; Renema J; Hulshoff A
Pharm Weekbl Sci; 1982 Apr; 4(2):25-31. PubMed ID: 6808457
[TBL] [Abstract][Full Text] [Related]
34. Potential anticancer agents. XX. 2. Quantitative structure--activity relationships (QSAR) in aromatic nitrogen mustards area.
Niculescu-Duvăz I; Stihi G; Crăescu T; Simon Z
Neoplasma; 1980; 27(3):271-8. PubMed ID: 7453847
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and cytotoxic activity of trisubstituted-1,3,5-triazines.
Arya K; Dandia A
Bioorg Med Chem Lett; 2007 Jun; 17(12):3298-304. PubMed ID: 17449247
[TBL] [Abstract][Full Text] [Related]
36. Isoindolo[2,1-c]benzo[1,2,4]triazines: a new ring system with antiproliferative activity.
Diana P; Martorana A; Barraja P; Lauria A; Montalbano A; Almerico AM; Dattolo G; Cirrincione G
Bioorg Med Chem; 2007 Jan; 15(1):343-9. PubMed ID: 17064918
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of tumor growth and neovascularization by an anti-gastric ulcer agent, irsogladine.
Ono M; Kawahara N; Goto D; Wakabayashi Y; Ushiro S; Yoshida S; Izumi H; Kuwano M; Sato Y
Cancer Res; 1996 Apr; 56(7):1512-6. PubMed ID: 8603395
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, structure and hypoxic cytotoxicity of 3-amino-1,2,4-benzotriazine-1,4-dioxide derivatives.
Jiang F; Weng Q; Sheng R; Xia Q; He Q; Yang B; Hu Y
Arch Pharm (Weinheim); 2007 May; 340(5):258-63. PubMed ID: 17464965
[TBL] [Abstract][Full Text] [Related]
39. Pharmacology of pentamethylmelamine in humans.
Benvenuto JA; Stewart DJ; Benjamin RS; Loo TL
Cancer Res; 1981 Feb; 41(2):566-9. PubMed ID: 6778609
[TBL] [Abstract][Full Text] [Related]
40. Prodrugs of hydroxymethylpentamethylmelamine: a principal active metabolite of the antineoplastic agent hexamethylmelamine.
Ghodrati F; Lavoie EJ
Drug Des Discov; 1994 Feb; 11(2):135-47. PubMed ID: 8075301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
